Sfoglia per Autore
High levels of maternal serum IL-17 and activin A in pregnant women affected by systemic lupus erythematosus
2011-01-01 Torricelli, M.; Bellisai, F.; Novembri, R.; Galeazzi, L. R.; Iuliano, A.; Voltolini, C.; Spreafico, A.; Galeazzi, M.; Petraglia, F.
Detection of anti-IFI16 antibodies by ELISA: clinical and serological associations in systemic sclerosis
2011-01-01 Costa, S.; Mondini, M.; Caneparo, V.; Afeltra, A.; Airò, P.; Bellisai, F.; Faggioli, P.; Gerli, R.; Lotzniker, M.; Meroni, P. L.; Morozzi, G.; Radice, A.; Riccieri, V.; Scarsi, M.; Sebastiani, G. D.; Sinico, R. A.; Tincani, A.; Gariglio, M.; Landolfo, S.
Prevalence of anti-Histone antibodies, their clinical significante and correlation with other autoantibodies in a color of italian scleroderma patients
2011-01-01 Morozzi, Gabriella; Bellisai, Francesca; Fineschi, Irene; Scaccia, Francesca; Pucci, Gabriella; Simpatico, Antonella; Tampoia, M; Chialà, A; Lapadula, G; Galeazzi, Mauro
Evaluation of the effect of Bosentan treatment on proinflammatory cytokine serum levels in patients affected by Systemic Sclerosis
2011-01-01 Bellisai, F.; Morozzi, G.; Scaccia, F.; Chellini, F0; Simpatico, A0; Pecetti, G.; Galeazzi, M.
Relationship between serum comp levels and serological markers of disease activity in rheumatoid arthritis patients treated with anti-tnf drugs. A study of the best way to manage indicators of response to therapy
2009-01-01 Fabbroni, Marta; Morozzi, Gabriella; Bellisai, Francesca; Bacarelli, MARIA ROMANA; V., Codullo; V., Riccieri; C., Montecucco; G., Valesini; Cevenini, Gabriele; Galeazzi, Mauro
Idiopathic recurrent pericarditis refractory to colchicine treatment can reveal tumor necrosis factor receptor-associated periodic syndrome
2009-01-01 Cantarini, Luca; Lucherini, ORSO MARIA; Cimaz, R; Baldari, Cosima; Bellisai, Francesca; ROSSI PACCANI, S; LAGHI PASINI, Franco; Capecchi, PIER LEOPOLDO; Sebastiani, Gd; Galeazzi, Mauro
Eosinophilia-associated muscle disorders:an immunohistological study with tissue localisation of major basic protein in distinct clinicopathological forms
2009-01-01 Cantarini, Luca; Volpi, Nila; Carbotti, Paola; Greco, Giuseppe; Aglianò, M; Bellisai, Francesca; Giannini, Fabio; Alessandrini, Carlo; Grasso, Giovanni; Galeazzi, Mauro
Safety and efficacy of etanercept in children with juvenile-onset Behcets disease.
2009-01-01 Cantarini, Luca; Tinazzi, I; Caramaschi, P; Bellisai, Francesca; Brogna, A; Galeazzi, Mauro
Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicenter prospective study of 1000 patients.
2009-01-01 Cervera, R; Khamashta, M. A; Shoenfeld, Y; Camps, M. T; Jacobsen, S; Kiss, E; Zeher, M. M; Tincani, A; Kontopoulou-Griva, I; Galeazzi, M; Bellisai, F; Meroni, P. L; Derksen, R. H. W. M; De Groot, P. G; Gromnica-Ihle, E; Baleva, M; Mosca, M; Bombardieri, S; Houssiau, F; Gris, J. -C; Quéré, I; Hachulla, E; Vasconcelos, C; Roch, B; Fernández-Nebro, A; Piette, J. -C; Espinosa, G; Bucciarelli, S; Pisoni, C. N; Bertolaccini, M. L; Boffa, M. -C; Hughes, G. R. V.
Efficacy and safety of anti-TNF-alpha therapy combined with cyclosporine A in patients with rheumatoid arthritis and concomitant hepatitis C virus infection
2009-01-01 Giannitti, Chiara; Benucci, M; Caporali, R; Manganelli, Stefania; Bellisai, Francesca; Sebastiani, Gd; Galeazzi, Mauro
Simultaneouspulmonary involvement, histologically proven, of sarcoidosis and rheumatoidarthritis.
2009-01-01 Leo, G; Iuliano, A; Spina, D; Bellisai, Francesca; Fioravanti, A; Galeazzi, Mauro
Treatment strategies for apatient with rheumatoid arthritis and hepatitis C.
2009-01-01 Giannitti, Chiara; Bellisai, Francesca; Ferri, C; Galeazzi, Mauro
Anti-cofactor autoantibodies in systemic lupus erythematosus: prevalence, clinical and HLA class II associations
2008-01-01 Sebastiani, G. D.; Morozzi, G.; Bellisai, Francesca; Fineschi, Irene; Bacarelli, M. R.; Simpatico, Antonella; Font, J.; Cervera, R.; Houssiau, F.; Fernandez-Nebro, A.; De Ramon Garrido, E.; De Pità, O.; Smolen, J.; Galeazzi, Mauro
Viral genotype and HLA class II alleles influence on extra-hepatic manifestations of chronic HCV infection
2008-01-01 Giannitti, C.; Morozzi, G.; D'Alfonso, S.; Bellisai, F.; Galeazzi, M.
Coexistence of the antiphospholipid syndrome and abdominal aortic aneurysm
2008-01-01 SZYPER-KRAVITZ, M.; Altman, A.; DE CARVALHO, J. F.; Bellisai, F.; Galeazzi, M.; Eshet, Y.; Shoenfeld, Y.
Infliximab treatment in a patient with systemic sclerosis associated with lung fibrosis and pulmonary hypertension
2008-01-01 Bargagli, Elena; Galeazzi, Mauro; Bellisai, Francesca; Volterrani, Luca; Rottoli, Paola
Low serum level of COMP, a cartilage turnover marker, predicts rapid and high ACR70 response to adalimumab therapy in rheumatoid arthritis
2007-01-01 Morozzi, G.; Fabbroni, M.; Bellisai, F.; Cucini, S.; Simpatico, A.; Galeazzi, M.
Safety of cyclosporin A in HCV-infected patients: experience with cyclosporin A in patients affected by rheumatological disorders and concomitant HCV infection
2007-01-01 Galeazzi, M.; Bellisai, F.; Giannitti, C.; Manganelli, S.; Morozzi, G.; Sebastiani, G. D.
Combination therapy with cyclosporine A and anti-TNF-alpha agents in the treatment of rheumatoid arthritis and concomitant hepatitis C virus infection
2007-01-01 Bellisai, F.; Giannitti, C.; Donvito, A.; Galeazzi, M.
Cartilage oligomeric matrix protein level in rheumatic diseases: potential use as a marker for measuring articular cartilage damage and/or the therapeutic efficacy of treatments
2007-01-01 Morozzi, G.; Fabbroni, M.; Bellisai, F.; Pucci, G.; Galeazzi, M.
| Titolo | Data di pubblicazione | Autore(i) | File | Abstract |
|---|---|---|---|---|
| High levels of maternal serum IL-17 and activin A in pregnant women affected by systemic lupus erythematosus | 1-gen-2011 | Torricelli, M.; Bellisai, F.; Novembri, R.; Galeazzi, L. R.; Iuliano, A.; Voltolini, C.; Spreafico, A.; Galeazzi, M.; Petraglia, F. | - | |
| Detection of anti-IFI16 antibodies by ELISA: clinical and serological associations in systemic sclerosis | 1-gen-2011 | Costa, S.; Mondini, M.; Caneparo, V.; Afeltra, A.; Airò, P.; Bellisai, F.; Faggioli, P.; Gerli, R.; Lotzniker, M.; Meroni, P. L.; Morozzi, G.; Radice, A.; Riccieri, V.; Scarsi, M.; Sebastiani, G. D.; Sinico, R. A.; Tincani, A.; Gariglio, M.; Landolfo, S. | - | |
| Prevalence of anti-Histone antibodies, their clinical significante and correlation with other autoantibodies in a color of italian scleroderma patients | 1-gen-2011 | Morozzi, Gabriella; Bellisai, Francesca; Fineschi, Irene; Scaccia, Francesca; Pucci, Gabriella; Simpatico, Antonella; Tampoia, M; Chialà, A; Lapadula, G; Galeazzi, Mauro | - | |
| Evaluation of the effect of Bosentan treatment on proinflammatory cytokine serum levels in patients affected by Systemic Sclerosis | 1-gen-2011 | Bellisai, F.; Morozzi, G.; Scaccia, F.; Chellini, F0; Simpatico, A0; Pecetti, G.; Galeazzi, M. | - | |
| Relationship between serum comp levels and serological markers of disease activity in rheumatoid arthritis patients treated with anti-tnf drugs. A study of the best way to manage indicators of response to therapy | 1-gen-2009 | Fabbroni, Marta; Morozzi, Gabriella; Bellisai, Francesca; Bacarelli, MARIA ROMANA; V., Codullo; V., Riccieri; C., Montecucco; G., Valesini; Cevenini, Gabriele; Galeazzi, Mauro | - | |
| Idiopathic recurrent pericarditis refractory to colchicine treatment can reveal tumor necrosis factor receptor-associated periodic syndrome | 1-gen-2009 | Cantarini, Luca; Lucherini, ORSO MARIA; Cimaz, R; Baldari, Cosima; Bellisai, Francesca; ROSSI PACCANI, S; LAGHI PASINI, Franco; Capecchi, PIER LEOPOLDO; Sebastiani, Gd; Galeazzi, Mauro | - | |
| Eosinophilia-associated muscle disorders:an immunohistological study with tissue localisation of major basic protein in distinct clinicopathological forms | 1-gen-2009 | Cantarini, Luca; Volpi, Nila; Carbotti, Paola; Greco, Giuseppe; Aglianò, M; Bellisai, Francesca; Giannini, Fabio; Alessandrini, Carlo; Grasso, Giovanni; Galeazzi, Mauro | - | |
| Safety and efficacy of etanercept in children with juvenile-onset Behcets disease. | 1-gen-2009 | Cantarini, Luca; Tinazzi, I; Caramaschi, P; Bellisai, Francesca; Brogna, A; Galeazzi, Mauro | - | |
| Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicenter prospective study of 1000 patients. | 1-gen-2009 | Cervera, R; Khamashta, M. A; Shoenfeld, Y; Camps, M. T; Jacobsen, S; Kiss, E; Zeher, M. M; Tincani, A; Kontopoulou-Griva, I; Galeazzi, M; Bellisai, F; Meroni, P. L; Derksen, R. H. W. M; De Groot, P. G; Gromnica-Ihle, E; Baleva, M; Mosca, M; Bombardieri, S; Houssiau, F; Gris, J. -C; Quéré, I; Hachulla, E; Vasconcelos, C; Roch, B; Fernández-Nebro, A; Piette, J. -C; Espinosa, G; Bucciarelli, S; Pisoni, C. N; Bertolaccini, M. L; Boffa, M. -C; Hughes, G. R. V. | - | |
| Efficacy and safety of anti-TNF-alpha therapy combined with cyclosporine A in patients with rheumatoid arthritis and concomitant hepatitis C virus infection | 1-gen-2009 | Giannitti, Chiara; Benucci, M; Caporali, R; Manganelli, Stefania; Bellisai, Francesca; Sebastiani, Gd; Galeazzi, Mauro | - | |
| Simultaneouspulmonary involvement, histologically proven, of sarcoidosis and rheumatoidarthritis. | 1-gen-2009 | Leo, G; Iuliano, A; Spina, D; Bellisai, Francesca; Fioravanti, A; Galeazzi, Mauro | - | |
| Treatment strategies for apatient with rheumatoid arthritis and hepatitis C. | 1-gen-2009 | Giannitti, Chiara; Bellisai, Francesca; Ferri, C; Galeazzi, Mauro | - | |
| Anti-cofactor autoantibodies in systemic lupus erythematosus: prevalence, clinical and HLA class II associations | 1-gen-2008 | Sebastiani, G. D.; Morozzi, G.; Bellisai, Francesca; Fineschi, Irene; Bacarelli, M. R.; Simpatico, Antonella; Font, J.; Cervera, R.; Houssiau, F.; Fernandez-Nebro, A.; De Ramon Garrido, E.; De Pità, O.; Smolen, J.; Galeazzi, Mauro | - | |
| Viral genotype and HLA class II alleles influence on extra-hepatic manifestations of chronic HCV infection | 1-gen-2008 | Giannitti, C.; Morozzi, G.; D'Alfonso, S.; Bellisai, F.; Galeazzi, M. | - | |
| Coexistence of the antiphospholipid syndrome and abdominal aortic aneurysm | 1-gen-2008 | SZYPER-KRAVITZ, M.; Altman, A.; DE CARVALHO, J. F.; Bellisai, F.; Galeazzi, M.; Eshet, Y.; Shoenfeld, Y. | - | |
| Infliximab treatment in a patient with systemic sclerosis associated with lung fibrosis and pulmonary hypertension | 1-gen-2008 | Bargagli, Elena; Galeazzi, Mauro; Bellisai, Francesca; Volterrani, Luca; Rottoli, Paola | - | |
| Low serum level of COMP, a cartilage turnover marker, predicts rapid and high ACR70 response to adalimumab therapy in rheumatoid arthritis | 1-gen-2007 | Morozzi, G.; Fabbroni, M.; Bellisai, F.; Cucini, S.; Simpatico, A.; Galeazzi, M. | - | |
| Safety of cyclosporin A in HCV-infected patients: experience with cyclosporin A in patients affected by rheumatological disorders and concomitant HCV infection | 1-gen-2007 | Galeazzi, M.; Bellisai, F.; Giannitti, C.; Manganelli, S.; Morozzi, G.; Sebastiani, G. D. | - | |
| Combination therapy with cyclosporine A and anti-TNF-alpha agents in the treatment of rheumatoid arthritis and concomitant hepatitis C virus infection | 1-gen-2007 | Bellisai, F.; Giannitti, C.; Donvito, A.; Galeazzi, M. | - | |
| Cartilage oligomeric matrix protein level in rheumatic diseases: potential use as a marker for measuring articular cartilage damage and/or the therapeutic efficacy of treatments | 1-gen-2007 | Morozzi, G.; Fabbroni, M.; Bellisai, F.; Pucci, G.; Galeazzi, M. | - |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile